Companies · Healthtech

Sevaro Health Inc

EAST BRUNSWICK · Healthtech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on Sevaro Health Inc — recommendation, valuation, rhythm, risks.
$46.0M
Total raised · real
2
Rounds
1.0×
Latest step-up
Top 11%
Sector rank · raised
Series B
Latest stage · inferred · Wed Jun 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Sevaro Health Inc looks over-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.80× the median modeled value of Series B Healthtech companies in 2025–2027 (55 peers) — value vs value, same stage and era.
Active
  • Last raise 13 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Sevaro Health Inc is one of 2138 Healthtech companies tracked from EAST BRUNSWICK. By capital raised it ranks among the largest (ahead of 90% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2025-06-11
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2023-02-13 Raised $11M (real) Modeled valuation $93M (est)$11M$93MSeries A2023Series B · 2025-06-11 Raised $35M (real) Modeled valuation $175M (est)$35M$175MSeries B2025Series B · 2025-06-11 Raised $35M (real) Modeled valuation $175M (est)$35M$175MSeries B2025+$35M+$35MCumulative $81M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$11.0M · 2023
Series B$35.0M · 2025
Series B extension$35.0M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$175.0M
Base estimate est.
$82.2M
Conservative case
$261.5M
Upside case
$194.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $92.5M · 2023-02-132023Series B · modeled $175.0M · 2025-06-11Series B · modeled $175.0M · 2025-06-112025
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
1.1 yr
Elapsed time used
1.1 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
14 mo
Avg between rounds
$19.8M/yr
Capital velocity
3.4 yr
On record since
2023
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 10× above median
This company$46.0M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.9× above median
This company$35.0M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 5.2× above median
This company$175.0M
Sector median$33.8M

Raised more than 90% of sector peers (real $). Modeled value above 85% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #1 of 55.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Field Medical, Inc. · Series B Raised $61.9M · modeled $172.8M (est)Berry Street Health, Inc. · Series B Raised $39.2M · modeled $170.0M (est)Puzzle Medical Devices Inc. · Series B Raised $30.0M · modeled $168.6M (est)Cartwheel Care Inc. · Series B Raised $35.2M · modeled $168.1M (est)Spiro Medical Inc. · Series B Raised $39.1M · modeled $156.6M (est)Nomad Health, Inc. · Series B Raised $106.9M · modeled $153.2M (est)Charta Health, Inc. · Series B Raised $30.1M · modeled $148.8M (est)Integrated Care Partners, Inc. · Series B Raised $55.0M · modeled $145.9M (est)Commons Clinic Inc. · Series B Raised $69.8M · modeled $145.0M (est)Lumata Health Inc. · Series B Raised $35.4M · modeled $131.3M (est)Okami Medical, Inc. · Series B Raised $77.2M · modeled $125.6M (est)Sevaro Health Inc (this company) Raised $46.0M · modeled $175.0M (est)Sevaro Health Inc
CompanyStageRaised · realValue · estvs peer med.
Sevaro Health Inc this companySeries B$46.0M$175.0M1.80×
Field Medical, Inc.Series B$61.9M$172.8M1.77×
Berry Street Health, Inc.Series B$39.2M$170.0M1.74×
Puzzle Medical Devices Inc.Series B$30.0M$168.6M1.73×
Cartwheel Care Inc.Series B$35.2M$168.1M1.72×
Spiro Medical Inc.Series B$39.1M$156.6M1.61×
Nomad Health, Inc.Series B$106.9M$153.2M1.57×
Charta Health, Inc.Series B$30.1M$148.8M1.53×
Integrated Care Partners, Inc.Series B$55.0M$145.9M1.50×
Commons Clinic Inc.Series B$69.8M$145.0M1.49×
Lumata Health Inc.Series B$35.4M$131.3M1.35×
Okami Medical, Inc.Series B$77.2M$125.6M1.29×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$11.0M2023-02-13$50.0M$92.5M90%
Series B$35.0M2025-06-11$194.4M$175.0M90%
Series B$35.0M2025-06-11$194.4M$175.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$11.0M2023-02-13
    • First recorded raise — entered as Series A.
    • 1 investor on this round.
  2. Series B$35.0M2025-06-11
    • Raised again after 28 mo — slower than the ~14 mo sector norm.
    • Round 3.2× larger than the prior — scaling up.
    • 3 investors on this round.
  3. Series B$35.0M2025-06-11
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 3 investors on this round.
Intelligence
2026 ~Q3
Modeled next raise · ~14mo cadence
$35.0M
Modeled next size est.range $35.0M$56.0M
1.0×
Last step-up
$19.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Anna Haghgooie10 other2025-06
Kapil Desai1 other2023-02
Ajay Sharma2023-02
Dr. Rajiv Narula2025-06
Krishan Narula2023-02
Rajiv Narula2023-02
Registry & provenance

Sevaro Health Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1966570
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Tava Health, Inc.HealthtechSeries B$28.9M$129.6Mnetwork1 shared operator · same sector · same stage
Solera Health, Inc.HealthtechSeries B$79.1M$935.6Mnetwork1 shared operator · same sector · same stage
Jukebox Health Inc.HealthtechSeries B$25.7M$117.7Mnetwork1 shared operator · same sector · same stage
Axial Healthcare, Inc.HealthtechSeries B$25.5M$422.3Mnetwork1 shared operator · same sector · same stage
Axial Healthcare Holdings, L.P.HealthtechSeries C$45.0M$408.6Mnetwork1 shared operator · same sector
Tryton Medical IncHealthtechSeries B$46.2M$99.1Msame sector · same stage
Visana Health, Inc.HealthtechSeries B$45.6M$113.2Msame sector · same stage
Vera Whole Health, Inc.HealthtechSeries B$46.4M$247.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Seigla Medical, Inc.HealthtechPre-Seed$2.9M86%
Oto Health Inc.HealthtechSeed$36.8M86%
Innoneo Health Technologies, IncHealthtechSeed$26.6M85%
Tava Health, Inc.HealthtechSeries B$129.6M85%
Healthe, Inc.HealthtechSeries B$465.2M85%
Hippo Health, Inc.HealthtechSeed$110.9M84%
Seikowave Health Solutions, Inc.HealthtechSeed$5.1M84%
Momo Medical Group Inc.HealthtechSeries A$41.8M84%
Frequently asked
How much funding has Sevaro Health Inc raised?
Sevaro Health Inc has raised approximately $46.0M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Sevaro Health Inc's estimated valuation?
Provath's modeled valuation for Sevaro Health Inc is approximately $175.0M (modeled range $82.2M–$261.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Sevaro Health Inc at?
Sevaro Health Inc's latest modeled financing stage is Series B. Its most recent recorded round closed around Wed Jun 11.
What does Sevaro Health Inc do and where is it based?
Sevaro Health Inc operates in the Healthtech sector, based in EAST BRUNSWICK.
Explore related

See where Sevaro Health Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Sevaro Health Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.